Novartis Ag (NVSEF) Profit After Tax (QoQ) (2009 - 2023)

Novartis Ag (NVSEF) Profit After Tax (QoQ) (2009 - 2023) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2023 346.44%
Mar 31, 2023 -86.74%
Dec 31, 2022 571.36%
Sep 30, 2022 -65.60%
Jun 30, 2022 184.87%
Mar 31, 2022 -87.99%
Dec 31, 2021 671.65%
Sep 30, 2021 -77.82%
Jun 30, 2021 463.23%
Mar 31, 2021 -87.28%
Dec 31, 2020 568.87%
Sep 30, 2020 -67.65%
Jun 30, 2020 862.37%
Jun 30, 2019 1,262.73%
Mar 31, 2019 2.89%
Dec 31, 2018 -17.38%
Sep 30, 2018 -92.44%
Jun 30, 2018 1,138.92%
Mar 31, 2018 22.22%
Dec 31, 2017 -12.61%